trial

Valnoctamide in Mania

NCTId NCT00140179
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Completed
Enrollment 80 (estimated)
Sponsored by Beersheva Mental Health Center
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Completed
Enrollment
80 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2004-09
Primary completion
—
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
valnoctamide

Sponsors

Beersheva Mental Health CenterLead Sponsor
Stanley Medical Research InstituteCollaborator

Investigators

1
RH Belmaker, MDStudy Director

Sites

3 total
Afula, IsraelAshkelon, IsraelBeersheva, Israel

Facts & assertions

3 sourced
Enrollment
80
Phase
PHASE3
Status
COMPLETED
relationships
The graph out of here
drug
valnoctamide
drug
lead_sponsor
Beersheva Mental Health Center
company
collaborator
Stanley Medical Research Institute
company
indication
Mania
indication
Teratogenesis
indication
Mania
indication
investigator
RH Belmaker, MD
person